TAG
PAXLOVID
FDA Approves Emergency Use Authorization (EUA) for Pfizer’s COVID-19 Oral Treatment in Phl
Data demonstrated an 89% and 88% reduction in risk of COVID-19-related hospitalization or death from any cause in adults treated with PAXLOVID within three...